Endovascular stroke trials: Why we must enroll all eligible patients

Stroke

Volumn 44, Issue 12, 2013, Pages 3591-3595

  Goyal, Mayank ^a   Shamy, Michel ^b   Menon, Bijoy K ^a   Saver, Jeffrey L ^c   Diener, Hans Christoph ^d   Mocco, J ^e   Pereira, Vitor Mendes ^f   Jovin, Tudor G ^g   Zaidat, Osama ^h   Levy, Elad I ⁱ   Davalos, Antoni ^a   Demchuk, Andrew ^j   Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e VANDERBILT UNIVERSITY   (United States)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ UNIVERSITY AT BUFFALO   (United States)

^j HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

more..

Author keywords

Acute stroke; Endovascular stroke treatment; Ethics; Randomized controlled trials; Trial enrollment

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; BIOETHICS; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CARDIOLOGY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY SURGERY; CAROTID ENDARTERECTOMY; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; DISEASE COURSE; DOCTOR PATIENT RELATION; DURAL ARTERIOVENOUS FISTULA; EMBOLECTOMY; EQUIPOISE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; NEUROLOGIST; NOTE; PATIENT AUTONOMY; PATIENT CARE; PATIENT SELECTION; PHLEBOTOMY; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; SOCIAL BEHAVIOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES;

ACUTE STROKE; ENDOVASCULAR STROKE TREATMENT; ETHICS; RAN DOMIZED CONTROLLED TRIALS; TRIAL ENROLLMENT;

CLINICAL TRIALS AS TOPIC; ENDOVASCULAR PROCEDURES; ETHICS, MEDICAL; ETHICS, RESEARCH; HUMANS; PATIENT SELECTION; STROKE; THROMBOLYTIC THERAPY;

EID: 84889255296     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002522     Document Type: Note

References (20)

1. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903.
2. Ciccone A, Valvassori L; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:2433-2434.
3. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-923.
4. Albuquerque FC, Fiorella D, Hirsch JA, Prestigiacomo C, Tarr RW. The tribulations of stroke trials. J Neurointerv Surg. 2013;5:181-183.
5. Parsons MW, Albers GW. MR RESCUE: is the glass half-full or halfempty? Stroke. 2013;44:2055-2057.
6. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc. 1999;282:2003-2011.
7. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249.
8. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240.
9. Strauss DC, Thomas JM. What does the medical profession mean by standard of care? J Clin Oncol. 2009;27:e192-e193.
10. Vickrey BG, Samuels MA, Ropper AH. How neurologists think: A cognitive psychology perspective on missed diagnoses. Ann Neurol. 2010;67:425-433.
11. Fried C. Medical Experimentation: Personal Integrity and Social Policy. Amsterdam: North-Holland Publishing 1974.
12. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [ist-3]): a randomised controlled trial. Lancet. 2012;379:2352-2363.
13. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141-145.
14. Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, Demchuk A, et al; IMS III Executive Committee. Equipoise among recanalization strategies. Neurology. 2010;74:1069-1076.
15. Bentham J. The Principles of Morals and Legislation. New York: Prometheus Books; 1988.
16. Miller FG, Brody H. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep. 2003;33:19-28.
17. Miller FG, Joffe S. Equipoise and the dilemma of randomized clinical trials. N Engl J Med. 2011;364:476-480.
18. Niiniluoto I. Fallibilismistä. Sosiologia. 1974;11:275-286.
19. Lyden PD, Meyer BC, Hemmen TM, Rapp KS. An ethical hierarchy for decision making during medical emergencies. Ann Neurol. 2010;67:434-440.
20. Mill JS. On Liberty and Other Writings. New York: Modern Library; 2002.